We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Alosetron Impurity 2
N-Nitroso Alosetron Impurity 2
CAT No SRC-N0142242
CAS No NA
Mol.F. C12H11N3O2
Mol.Wt. 229.24 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Alosetron Impurity 3
N-Nitroso Alosetron Impurity 3
CAT No SRC-N0142243
CAS No NA
Mol.F. C11H9N3O2
Mol.Wt. 215.21g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Alosetron Impurity 4
N-Nitroso Alosetron Impurity 4
CAT No SRC-N0142244
CAS No NA
Mol.F. C16H15N5O2
Mol.Wt. 309.33 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Pacritinib
N-Nitroso Pacritinib
CAT No SRC-N0142245
CAS No NA
Mol.F. C28H31N5O4
Mol.Wt. 501.59 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Pacritinib Impurity 1
N-Nitroso Pacritinib Impurity 1
CAT No SRC-N0142246
CAS No NA
Mol.F. C24H23ClN4O4
Mol.Wt. 466.92 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso Pacritinib Impurity 2
N-Nitroso Pacritinib Impurity 2
CAT No SRC-N0142247
CAS No NA
Mol.F. C26H27ClN4O4
Mol.Wt. 494.98 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso Pacritinib Aldehyde Impurity
N-Nitroso Pacritinib Aldehyde Impurity
CAT No SRC-N0142248
CAS No NA
Mol.F. C28H31N5O5
Mol.Wt. 517.59 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso Altizide Impurity 1
N-Nitroso Altizide Impurity 1
CAT No SRC-N0142249
CAS No NA
Mol.F. C11H13ClN4O5S3
Mol.Wt. 412.89 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Alverine Impurity D
N-Nitroso Alverine Impurity D
CAT No SRC-N0142250
CAS No NA
Mol.F. C18H28N2O
Mol.Wt. 288.44 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Alverine Impurity 1
N-Nitroso Alverine Impurity 1
CAT No SRC-N0142251
CAS No NA
Mol.F. C24H30N2O8
Mol.Wt. 474.51 g/mole
INV STATUS UNDER SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.